Experienced in Factor 7 Deficiency

Emmanuel De Maistre

CHU Dijon Bourgogne
Dijon, FR 
Experienced in Factor 7 Deficiency
CHU Dijon Bourgogne
Dijon, FR 
OverviewLocationsClinical Research

Overview

Emmanuel De Maistre practices in Dijon, France. Mr. De Maistre is rated as an Experienced expert by MediFind in the treatment of Factor 7 Deficiency. His top areas of expertise are Prothrombin Deficiency, Thrombocytopenia, Blood Clots, and Factor 13 Deficiency.

His clinical research consists of co-authoring 74 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Factor 7 Deficiency.

Gender
Male

Locations

CHU Dijon Bourgogne
Dijon, 21000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia
Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia
Enrollment Status: Active_not_recruiting
Publish Date: June 18, 2024
Intervention Type: Biological
Open-Label, Randomised, Active Controlled, Multi-Centre Ph 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Acute HIT
Open-Label, Randomised, Active Controlled, Multi-Centre Ph 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Acute HIT
Enrollment Status: Terminated
Publish Date: December 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding
Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding
Enrollment Status: Completed
Publish Date: June 10, 2022
Intervention Type: Other
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Other
View 3 Less Clinical Trials

74 Total Publications

Usefulness and Limits of DOAC Removal Agents Based on Activated Charcoal in Thrombophilia Testing: Literature Review and Expert Proposals.
Usefulness and Limits of DOAC Removal Agents Based on Activated Charcoal in Thrombophilia Testing: Literature Review and Expert Proposals.
Journal: Thrombosis and haemostasis
Published: September 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Maistre's expertise for a condition
ConditionClose
      View All 27 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile